WHO-GMP & ISO 9001:2015 Certified • Indian Icon Award 2026 Winner
NASAL SPRAYS • NASAL SPRAYS

NASRIO-MARK II – Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler

Generic Medicine Name: Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler (NASAL SPRAYS)

View All Formulations of Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler »
Schedule H Prescription Drug
Printed MRP: ₹250.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
2 in 1 Inhaler
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
NASRIO-MARK II Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name NASRIO-MARK II
Active Formulation (Salt) Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler
Dosage Form NASAL SPRAYS
Packaging Presentation 2 in 1 Inhaler
Therapeutic Category NASAL SPRAYS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is NASRIO-MARK II (Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler)?

Therapeutic monograph and clinical profile

NASRIO-MARK II (Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 2 in 1 Inhaler, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Nasal Congestion /Dizziness & Faintness.

Key Formulation Highlights

Why healthcare professionals recommend NASRIO-MARK II

WHO-GMP & ISO 9001:2015 Certified Manufacturing
Exclusive PCD Franchise Monopoly Rights Available
High Bioavailability & Lab-Tested Purity (Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler)
Tamper-Proof Pharmaceutical Packaging (2 in 1 Inhaler)
Prompt Pan-India Logistics & Marketing Promotional Support

Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Nasal Congestion /Dizziness & Faintness

Pharmacological Mechanism of Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler

How NASRIO-MARK II acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for NASRIO-MARK II

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for NASRIO-MARK II across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding NASRIO-MARK II

What is NASRIO-MARK II used for?
NASRIO-MARK II is clinically indicated for Nasal Congestion /Dizziness & Faintness. Always follow dosage instructions from a qualified medical practitioner.
What is the active composition of NASRIO-MARK II?
Each unit of NASRIO-MARK II contains Eucalyptus Oil , Camphor, Borneol & Menthol Inhaler, manufactured under strict pharmacopoeial IP/BP/USP standards.
How can I get monopoly PCD franchise for NASRIO-MARK II in my district?
Riomedica Healthcare offers monopoly PCD pharmaceutical franchise rights for NASRIO-MARK II. Contact our business development desk via the monopoly enquiry form or WhatsApp for prompt approval.
What is the packaging and MRP of NASRIO-MARK II?
NASRIO-MARK II is supplied in 2 in 1 Inhaler at an MRP of ₹250.00. Attractive wholesale margins and promotional support are provided to franchise partners.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.

OFFICIAL APP Get Android App